Facebook Linkedin Mail X Youtube
Facebook Linkedin Mail X Youtube
    7 days popular

    Features

    Research aims to understand training needs for left-handed cardiac surgeons

    Attention turns to multi-organ denervation as new evidence supports “durability” of blood pressure reductions

    Robotic aortic valve replacement offers an “exciting new chapter” in the treatment of aortic valve disease

    EACTS past president puts innovation and inclusivity at the top of the agenda

    STS risk calculator uses power of big data to predict cardiac surgery risk

    From the heart of the Andes to the hearts of children

    “TAVI was my baby, now it is a teenager”

    BIBA Briefings: Sapien 3 becomes first TAVI valve to be approved for low-risk patients in both Europe and the USA

    Settling the paclitaxel versus sirolimus DCB debate

    Putting “stent regret” behind us

    Preventing kidney damage in the cath lab

    Ostial left anterior descending arteria stenosis treated by percutaneous coronary intervention and Promus Element everolimus-eluting stent system

    The risks and benefits of exercise after a myocardial infarction

    Myval: India’s TAVI technology is now going global

    Artificial intelligence is being explored as a new tool for diagnosing coronary artery disease

    Timir K Paul

    Downgraded guideline recommendations on embolic protection during saphenous vein graft intervention are a step in the right direction   

    How the LightLab initiative is examining the value of OCT in the cath lab

    Understanding trends in TAVI and surgical aortic valve replacement

    interventional cardiology trials

    The interventional cardiology trials to watch in 2023

    Challenges establishing minimally invasive cardiac surgery in the developing world

    ADVERTORIAL: Know where you are with SyncVision technology

    The role of psychological support after a myocardial infarction

    “There’s no meeting like it”: Stage is set for CX Aortic Live 2024

    Female representation in interventional cardiology remains low, but there is cause for hope

    ADVERTORIAL Early results for HAART 200 and HAART 300 Aortic Annuloplasty Devices are encouraging

    The benefits of optical coherence tomography in the cath lab

    Optimising pharmacology after transcatheter aortic valve replacement: Lessons from the POPular TAVI trial

    The evolution of PCR: milestones and achievements in its 30-year journey

    Renal denervation finds new shores following US FDA device approvals

    Medtech Insights: Transcatheter tricuspid therapies “on the cusp of becoming standard of care”

    Interventional cardiology in the Twitterverse

    Leaflex: Changing the conversation around aortic stenosis?

    Huge progress needs to be made before bioresorbable stents can replace permanent stents

    Third-generation drug-eluting stents and beyond: Where were we, where are we, and where we are heading

    What they don’t teach in fellowship: Business insights for young cardiologists

    Ruby anniversary: The key revolutions of the past 40 years

    pascal repair

    ADVERTORIAL: Edwards PASCAL™ Transcatheter Valve Repair System is innovative

    The role of nurses in ensuring a patient-focused TAVI service

    Improved follow-up care needed for Black patients post-PCI to prevent hospital readmission and death

    renal denervation

    Money-maker or meritable: Is renal denervation out of retirement?

    FAST II underscores vFFR as a “faster and easier” physiological lesion assessment tool

    ADVERTORIAL: “We are now at a new era of TAVI where we have very high rates of device success”

    TAVI at the end of life: Knowing when it is futile

    TVT 2018: New-generation TAVI devices perform well in patients with large annuli

    Low-risk TAVI trials underscore optimism for transcatheter approach but surgical societies reserve caution

    Further innovation and research is required for thrombus aspiration in PCI

    From SYMPLICITY HTN-1 to SPYRAL HTN-OFF MED: The story of renal denervation

    Novel tricuspid therapy wins the 2016 EACTS Techno College Innovation Award

    ADVERTORIAL: Device and procedural innovations have led to improved efficiency with TAVI

    New Liverpool Centre for Cardiovascular Science established

    “Not just inventing the next stent”: The future of medtech relies on patient empowerment

    “Communication is key” when managing patients who seek discharge against medical advice

    What is required for TAVI to become the new gold standard?

    An inside view into the FAST trial

    Lessons from SURTAVI

    Cardiologists without borders

    ADVERTORIAL: Enhanced deliverability means Trifecta™ valve is now easier to implant

    Use of Impella CP is feasible in patients with severe aortic stenosis during high-risk percutaneous coronary intervention

    Digital learning is becoming a part of the “new normal”

    Reducing periprocedural complications is key for the future use of TAVI in lower-risk patients

    Minimally invasive aortic perfusion cannula receives EACTS Techno-College innovation award

    Determining valve durability in the era of TAVI

    Intravascular lithotripsy: A novel technology for treating calcified coronary stenoses

    Cardiovascular News’ top stories of 2022

    “We really believe that the transradial approach is a better way to do cardiac catheterisations”

    Will the NHS broaden its commissioning criteria for TEER?

    Cardiovascular News’ top stories of 2023

    BIBA Briefings: Longest and largest follow-up data for Watchman supports its role in stroke prevention

    The SCOUT study: Transcatheter tricuspid repair

    CX Aortic Vienna

    CX Aortic Vienna: Cardiac and vascular surgeons collaborate at the vanguard of aortic care

    “New generation TAVI devices will push complication rates down”

    A smartphone app to assist valve-in-valve procedures

    Debates to unpick controversies in aortic repair at CX 2024

    Philips’ Bert van Meurs discusses the future of imaging in the cath lab

    Medtech Insights: Trial pipeline underpins growth strategy for Watchman LAAC device

    EACTS panel sounds call to action over sex disparities in coronary surgery

    Cancer patients should not automatically be excluded from TAVI

    TAVI-proof procedures and device designs

    Spotlight turns to TAVI in patients with moderate aortic stenosis

    Team-centred approach is best way of determining need for PFO closure

    ADVERTORIAL: Tricuspid annular reduction using Edwards Cardioband (TM) Tricuspid Valve Reconstruction System in a patient with severe tricuspid regurgitation and large coaptation gap

    CardioRisk: Addressing atherosclerotic risk factors among Egypt’s ACS patients

    Managing mild paravalvular leak after TAVI

    Study indicates that anger or emotional upset can trigger a myocardial infarction

    The Tricento transcatheter heart valve: A novel approach for the treatment of tricuspid regurgitation

    Increased rate of acute myocardial infarction during pregnancy linked to increase in older mothers

    Late-breaking science is alive and well despite the pandemic

    Opinion: The value of FAME

    Approval of Tendyne TMVI device means physicians now have a portfolio of options for treating mitral regurgitation

    Identifying an alternative to drug-eluting stents for treating bifurcation lesions

    Sharing international insight to improve the cardiovascular treatment pathway

    Multidisciplinary teams at the heart of new guidelines on aortic disease management

    Bicuspid aortic stenosis: TAVI’s next challenge

    ADVERTORIAL: Edwards Cardioband™ Mitral Valve Reconstruction System—Reliably addressing annular dilatation

    Using telemedicine to transform the management of acute myocardial infarction: the Latin America telemedicine infarct network (LATIN) experience

    Leaflex Performer: A non-implant based treatment for aortic stenosis

    NORSTENT shows bare metal stents have improved

    Intravascular lithotripsy: Not an eccentric option for eccentric calcium

    Do drug-eluting stents increase the rate of late stent thrombosis compared to bare metal stents in STEMI patients? The DESERT cooperation

    ESC 2020 Congress: Digital platform takes congress to a wider audience

    Abbott’s Nick West points to future role of AI in the cath lab

    The risk of stroke in patients undergoing TAVI

    EACTS puts innovation to the fore

    New minimal-invasive aortic valve resecting tool

    Expanded robotic training will benefit cardiovascular care

    Helping Little Hearts to mend

    Aortic advances: New techniques and technologies in the spotlight

    More data in support of newer generation stents for high bleeding risk patients

    The influence of technology and robotics in the catheterisation laboratory is growing

    The findings on transcatheter aortic valve implantation in patients who are at low risk for cardiac surgery will usher in a new era for patients

    Advertorial: iFR Scout pullback assessment is “much more discriminatory” than FFR pullback assessment

    CX returns to in-person format once more in the London spring

    ADVERTORIAL: Rethinking the future of cardiology imaging

    ADVERTORIAL: Answering the question of durability is TAVI’s next challenge

    MedShr: A physician-designed online platform for case discussion

    Viagra may reduce cardiovascular outcomes after a first myocardial infarction

    Robotic treatment starts with the heart

    Online medical information: A blessing or a curse?

    Infection in the setting of STEMI

    It is time for a SYNTAX-like trial for transcatheter valves

    The US should follow Europe’s lead and change guidelines on embolic protection in saphenous vein grafting

    Perform PCI prior to TAVI in patients with both coronary artery disease and aortic stenosis

    Assessing non-obstructive coronary disease in the cath lab: A tailored approach to treat anginal symptoms

    Transradial access will probably become the default primary PCI strategy

    Progress in transcatheter heart valve techniques

    First ESC/EACTS guidelines on coronary revascularisation

    Sham-controlled trials prompt renal denervation hypertension guideline update

    Mitral valve repair in severe mitral regurgitation: An interventional cardiologist’s perspective

    Study to explore shortest-ever duration of triple therapy after PCI

    CX 2022 returns to in-person format facing challenges and opportunities in the aortic field

    New appropriateness criteria guide treatment of patients with heart blockage

    Interventional cardiologists may have “a false sense of security” about radiation safety

    Novel device “safely obliterates” left atrial appendage with minimal amount left behind

    ESC 2017: Alternative strategies needed for treating stenotic lesions in saphenous vein grafts

    Soft robotic heart could be answer to donor heart shortage

    Using dobutamine stress echocardiography to identify true-severe aortic stenosis

    Bifurcation lesions: When a two-stent technique is needed

    BASILICA: A new approach for preventing coronary obstruction in TAVI

    Opinion: “Why we prefer the minicrush as a two-stent strategy”

    Cardiovascular-aortic community comes together at CX 2023

    Atherectomy is an important tool for optimising results of PCI in calcified lesions

    Minimally invasive aortic valve surgery or TAVI: The need for randomised trials

    PCR LV 2017: The optimal modalities for imaging for mitral and tricuspid valve interventions

    Renal denervation “can reach new shores”

    Use of fusion imaging during TAVI

    The first 60 years of cardiac pacing

    paclitaxel

    Without additional long-term and patient-level data, Katsanos et al’s conclusion is premature

    IVL is a safe and predictable tool against coronary calcium

    Combing intravascular ultrasound with multispectral fluorescence lifetime imaging may provide comprehensive insights into lesion formation

    ACUITY one-year sub-analysis published

    “MRI is more accurate than SPECT in detecting the presence of significant coronary artery disease”

    The economics of TAVI

    The management of leaflet thickening after TAVI remains controversial

    CX Aortic Vienna

    Cardiac, vascular and endovascular leaders convene for CX Aortic Vienna

    TAVI durability: A rose by any other name is still a rose

    Ruby anniversary: Peculiarities about the world’s first PCI

    Increased use of left ventricular assist devices could improve heart failure survival

    Optimising care through the heart team approach

    Strut coverage: Optical coherence tomography and new stent technologies

    Heart failure guidelines focus on key research findings, clinical advances

    We need to embrace digital education and adapt it to improve patient care—reflections from the ESC

    ADVERTORIAL: Edwards’ CardiobandTM Tricuspid Valve Reconstruction System: A new option for under-treated patients

    Take care from start to finish: Avoiding radial artery occlusion

    Are there gender-related factors influencing the outcome of TAVI patients?

    Is magnetic resonance imaging a useful tool to identify the cause of malignant ventricular arrhythmias?

    Can we mend a broken heart?

    Renal denervation still holds strong potential as a therapy for hypertension

    Minimally invasive TAVI has “several potential benefits”

    “Tantalising” data open the door for further study of mechanical aspiration thrombectomy with PCI

    An “opt-out” approach may encourage more patient participation in research

    ADVERTORIAL: Taking control of LDL-C when statin therapy is not enough

    New approach for aortic valve replacement is feasible

    Revised European guidelines on cardiovascular disease prevention: What you need to know

    A “crackdown” on alternative access for TAVI

    Finding the roots of the disease before treating it: Modelling NSTEMI

    ADVERTORIAL: Unique design and features of the ACURATE neo (TM) enable safe and efficient procedures

    Elderly HF patients do not benefit from intensive medical therapy

    COVID-19: Robotics may help to reduce exposure to virus patients during interventional procedures

    Trials on newer generation drug-eluting stents in small coronary vessels needed

    Balloon aortic valvuloplasty in the current era

    (Drug-eluting?) Coronary stenting in patients on chronic oral anticoagulation

    Back in the room: A welcome return to in-person education

    Portsmouth Hospital: How tech is guiding decision-making in the cath lab

    “Our goal is to treat more patients with mitral regurgitation”

    Non beta-blocker therapies are infrequently used in patients experiencing angina after PCI

    “Tricuspidisation” could be a potential approach to performing TAVI in certain patients with bicuspid valves

    COVID-19: We have used YouTube to encourage STEMI patients to come to hospital

    Transseptal puncture techniques must be mastered if physicians wish to perform left-sided interventions

    ESC updates guidelines for STEMI, heart failure and pulmonary embolism

    New data from the SOURCE registry

    A bold new study could alter the orbit of elective PCI

    COVID-19: Education in the time of coronavirus

    ASH: ARB combinations effective across subgroups

    TCT 2018: Multivessel NIRS is feasible, safe and can predict future events

    The ATI score: A new tool to triage novel treatments in patients with myocardial infarction

    The National Cardiovascular Data Registry is a “national treasure”

    Challenges of conducting a randomised clinical trials to prove the impact of mechanical circulatory support in cardiogenic shock

    Understanding and managing functional tricuspid regurgitation

    TCT 2017: TMVI in mitral ring is a reasonable alternative for high-risk patients

    Transcatheter tricuspid valve repair shows promise for reducing heart failure hospitalisations

    Data and debate to bring new light to aortic controversies at CX 2024

    EACTS 2018: From bench to bedside: Roundtrip for cell therapy in heart disease

    ADVERTORIAL: Edwards PASCAL™ Transcatheter Valve Repair System is associated with a “striking” reduction in mitral regurgitation

    Techno-College Innovation Award for LifeMatrix bioengineering platform

    Less strict heart rate control is effective

    EU project will develop computer models of the heart

    “Keep it fast and simple” to avoid periprocedural stroke after TAVI

    The resurgence of renal denervation

    Opinion: From here to JUPITER

    ADVERTORIAL: The Edwards Cardioband™ Tricuspid Valve Reconstruction System is associated with considerable improvement in functional outcomes

    The implications of ABSORB II three-year results for the future of bioresorbable scaffolds

    Performing TAVI in patients with carotid artery disease

    The role of fractional flow reserve in managing STEMI patients with multivessel disease

    Ticagrelor may be an effective tool for suppressing platelet reactivity after TAVI

    ADVERTORIAL: What does SCOPE II tell us about TAVI device trials?

    Revising the National Coverage Determination for TAVI: The real barrier to care is not volume requirements

    Understanding the risk of acute kidney injury in the cath lab

    Orsiro may be the new benchmark for comparison in drug-eluting stent trials

    Pacemaker dependency after transcatheter aortic valve implantation

    “Interventional cardiology is losing more than 50% of the talent pool”

    RE-ACCESS study has implications for TAVI valve selection

    Alternatives to today’s drug-eluting stents

    TCT 2017: The HREVS study provides supportive evidence for the hybrid revascularisation approach

    The number of metallic layers affects efficacy of drug-coated balloons for in-stent restenosis

    atman-shah-cardiology

    Video games can take cardiology training to the next level

    Study finds that initiatives to improve medication adherence after myocardial infarction do not work

    Acute iFR evaluation may be a valid approach for ruling out non-culprit lesions in STEMI patients

    Novel repositionable TAVI valve has acceptable early clinical outcomes

    ADVERTORIAL: Sentinel Cerebral Protection System provides reassurance to both physicians and patients

    Further innovation and research is required for thrombus aspiration in PCI

    Targeted healing: A new stent concept that could contribute to shortened DAPT

    Timeline: Key milestones in the paclitaxel story

    TAVI pacemaker issue is “an engineering problem that will be solved”

    New ATHENA data suggest decrease in stroke risk with dronedarone for AF

    Simplified TAVI device may benefit patients with rheumatic heart disease

    Several barriers need to be overcome to make “telestenting” feasible

    EXCEL may damage relations between interventional cardiologists and cardiac surgeons

    Transitioning from transfemoral to transradial: Why the transradial approach is here to stay

    Using the heart team approach for congenital heart disease benefits both patients and parents

    The SOURCE registry in the context of PARTNER

    Combined percutaneous treatment of aortic stenosis and mitral regurgitation is feasible

    AtriCure agrees to buy LARIAT developer SentreHEART

    Ruby anniversary: 1977 – A remarkable year for kings and queens

    ADVERTORIAL: ACURATE neo: A “very safe” TAVI system providing “extremely good results in almost all patients”

    Drug-coated balloons for the management of coronary artery disease

    Renal denervation: The most advanced and efficacious interventional approach to treat hypertension

    Exploring the borders of TAVI

    TCT 2018: Sham-controlled trial indicates indirect annuloplasty reduces mitral regurgitation

    Raising the bar for competency in high-risk coronary procedures

    The need to determine the relevance of stent malapposition

    BIBA Briefings: Award for film raising awareness of aortic dissection

    TVT 2017: “I predict a very exciting and bright future” for transcatheter valve therapies

    BIBA Briefings: Henry V can inspire us to develop innovative techniques for reducing radiation exposure

    New data underpin drive towards earlier AF ablation strategies

    Primary PCI as a national reperfusion “strategy” for STEMI

    The risk of acute kidney injury during complex cardiac interventions: Rationale of the STRENGTH study

    Babies’ rapid weight gain linked to higher blood pressure as adults

    Standardisation paper aims to enhance uniformity of FFR in clinical practice

    Reducing aggressive and rude communication helps both doctors and patients

    Cardiology studies on the decline

    EuroPCR 2017: PCI outperforms medical management for treatment of chronic total occlusions

    The evolution of percutaneous valve technology

    A new percutaneous approach for managing mitral valve regurgitation

    Edwards Lifesciences drops Centera in favour of focusing on Sapien range

    Getting to grips with social media

    Retrograde coronary revascularisation in Europe to treat chronic total coronary occlusions

    Poll favours interventional radiologists to perform mechanical thrombectomy in lieu of neurointerventionalists

    Warfarin seriously underused despite efficacy in preventing stroke

    Pioneer of interventional cardiology in China receives Ethica Award 2011

    Patients benefit from participating in clinical trials

    A less invasive approach to cardiac assist device therapy

    Focusing on risk-adjusted mortality in public reporting produces misleading figures

    Caucasians have a higher incidence of an out-of-hospital cardiac arrest but risk of death is higher in African Americans.

    Europe on the front line of transcatheter aortic valve advancement

    Exploring new transcatheter options for the mitral valve

    PCI and bypass graft surgery: Which intervention and in whom?

    EuroPCR 2017: A “golden era” for valve disease therapies

    Building the ideal heart team for transcatheter mitral valve interventions

    Manage the risk of complications in CTO-PCI

    COVID-19: Optimising heart failure management in the patient’s home

    Using remote learning to improve high-risk PCI outcomes

    Survey reveals major gap between prevention guidelines and reality

    Complete PCI in STEMI: An interventional paradigm shift

    “Wait-and-see” is not an option with the new device regulations

    Transcatheter mitral interventions: MitraClip and beyond

    ACC 2017: Dual anti-thrombotic approach has similar risk of bleeding to dual antiplatelet therapy

    Tips and tricks for achieving optimum results with a drug-coated balloon

    Invasive strategy provides better outcomes for very elderly patients with NSTEACS

    Non-invasive FFRCT could transform management of coronary artery disease

    Omega-3 apparently beneficial in heart failure, but rosuvastatin fails

    An interventional cardiologist’s view on left atrial appendage closure

    The current status of transcatheter pulmonary valve replacement

    The need to determine the relevance of stent malapposition

    Psychological factors before and after renal denervation for resistant hypertension

    The data for thrombectomy are conflicting

    The importance of the PLATINUM DIVERSITY trial

    Audio: Interview with Prof Didier Carrié

    First transcatheter tricuspid valve replacement performed in the USA

    TCT 2017: Vivek Reddy on the final outcomes of PREVAIL and PROTECT-AF

    Pulmonary artery denervation: A novel approach to managing pulmonary hypertension

    International medical graduates in US cardiovascular care are vital to healthcare in the USA and beyond

    Cardiothoracic surgeons mobilised for COVID-19 research

    Optical coherence tomography to detect incomplete tissue coverage of metallic stent struts

    Predictors of cardiac death in patients with coronary chronic total occlusion not revascularised by PCI

    Clinical vs. anatomical risk stratification following complex PCI

    ICI meeting is a “fruitful ground for new developments” in interventional cardiology

    “There is a great deal of excitement about renal denervation among interventional cardiologists”

    The future of patent foramen ovale closure after the RESPECT and PC trials

    ESC 2017: Further decreasing mortality after STEMI will be difficult

    What to expect from AHA 2021

    Profiling plaque to guide treatment of coronary artery disease

    Treadmill therapy can improve mobility in stroke victims

    Rediscovering the transfemoral approach for structural heart interventions

    SCAI 2018: 3D model could be used to predict paravalvular leak after TAVI

    Mild heart failure: The REVERSE findings

    Optimising the management of older patients with STEMI

    SERVE-HF could be a wake-up call for cardiologists about central sleep apnoea

    Further studies needed to find effective treatment for reperfusion injury

    COVID-19: How the Egyptian cardiology departments are managing the pandemic

    Impaired cardiac baroreflex sensitivity predicts response to renal sympathetic denervation

    What role will remote robotic procedures play in the future of PCI?

    Marital status may influence risk of cardiovascular outcomes after myocardial infarction

    Echocardiographic essentials for TAVI

    Cardiology societies come together to provide key advice for dealing with ionising radiation

    The role of sutureless and rapid-deployment valves

    Wrist-worn heart rate monitors have variable accuracy

    Patients at limited compliance or non-responsiveness to double antiplatelet therapy

    GATEWAY Registry: Addressing bleeding risk in patients with acute coronary syndrome

    Combining MitraClip mitral valve repair with left atrial appendage occlusion is safe and feasible

    Cardiac Myosin-binding Protein C: Improving chest pain triage by using a novel marker of myocardial injury

    Performing PCI in comatose survivors of cardiac arrest

    COVID-19: “Communities of colour are at ground zero for this crisis”

    The second generation of drug-eluting stents with biodegradable polymers may have potential advantages

    Performing TAVI in a hybrid operating room

    Type A dissection enters a new revolution

    Percutaneous coronary intervention in patients with severe aortic stenosis: Implications for TAVI

    Procedural complexity should be considered when deciding duration of dual antiplatelet therapy

    COVID-19 is “here to stay” and new registry will provide important insights

    Tailoring dual antiplatelet therapy duration for an individual patient

    Training is the key to wider adoption of the transradial approach for PCI in the USA

    Reconciling the contrasting findings on MitraClip, and implications for the management of functional mitral regurgitation

    Prasugrel or ticagrelor should be administered to patients at clinical high risk for stent thrombosis

    A new percutaneous approach for managing mitral valve regurgitation

    “This is a very good time to hop on the wagon and learn about 3D echocardiography”

    The transformation of the coronary stent

    Children: A forgotten population

    Robotic PCI could be used to reduce radiation exposure to the operator

    Secondary prevention of cardiovascular disease in Europe: Prescribing pills is not sufficient

    Can we reduce paravalvular regurgitation after TAVI?

    The role of rotational atherectomy in contemporary PCI practice

    ADVERTORIAL: “All patients” should receive cerebral protection when undergoing TAVI procedures

    Exploring the role of P2Y12 inhibitor monotherapy after dual antiplatelet therapy

    Key factors for valve-in-valve procedural success

    The use of vascular robotic systems for PCI

    Previous guidelines were “overconfident” about benefits of P2Y12 inhibitor pre-treatment

    Good care means ensuring patients are thoroughly informed

    Coronary revascularisation in diabetic patients: Where do we stand?

    The “absolute priority” is to develop onco-cardiology guidelines to help clinicians

    Pre-hospital therapeutic hypothermia may not be beneficial

    Go “slender” to reduce the rate of radial artery occlusions

    “Encouraging” results for transcarotid TAVI

    Radiation exposure during coronary angiography via transradial or transfemoral approaches: Does operator experience matter?

    Knowing the long-term benefits of renal denervation is a priority

    Bioresorbable valves: Insights into a potential game-changing technology

    Most read

    Features

    Profiles

    Bernardo Cortese

    Roxana Mehran

    Patrick Myers

    Cardiovascular News

    Write to us
    Editorial: Will Date will@bibamedical.com
    Advertising: Hannah Shiels hannah@bibamedical.com


    BIBA Medical, Europe
    526 Fulham Road, Fulham, London, SW6 5NR
    TEL: +44 (0)20 7736 8788
    Email: info@bibamedical.com

    Terms and Conditions | Privacy Policy
    Facebook Linkedin Mail X Youtube